These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6386483)

  • 1. Quantitative and qualitative effects of m-AMSA (amsacrine) on cellular immune components.
    Miller T; Bleumink N
    Eur J Cancer Clin Oncol; 1984 Oct; 20(10):1307-16. PubMed ID: 6386483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of m-AMSA on rat isolated heart.
    Merkin MS; Shinar E; Shefer A; Gotsman MS; Hasin Y
    Clin Exp Pharmacol Physiol; 1985; 12(2):131-8. PubMed ID: 3839172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic effects of amsacrine on human lymphocytes in vivo and in vitro.
    Kao-Shan CS; Micetich K; Zwelling LA; Whang-Peng J
    Cancer Treat Rep; 1984; 68(7-8):989-97. PubMed ID: 6204755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of AMSA, an antineoplastic agent, on spermatogenesis in the mouse.
    da Cunha MF; Meistrich ML; Finch-Neimeyer MV
    J Androl; 1985; 6(4):225-9. PubMed ID: 3839780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An assessment of the immunosuppressive activity of the anti-tumour compound--4'-((9-acridinyl)amino)methanesulphon-m-anisidide (m-AMSA).
    Baguley GC; Falkenhaug EM; Rastrick JM; Marbrook J
    Eur J Cancer (1965); 1974 Mar; 10(3):169-75. PubMed ID: 4609763
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhanced killing of mammalian cells by radiation combined with m-AMSA.
    Roberts PB; Millar BC
    Br J Cancer; 1980 Nov; 42(5):684-91. PubMed ID: 6893934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. m-AMSA: a new anticancer agent.
    Rozencweig M; Von Hoff DD; Legha SS; Cysyk RL; Muggia FM
    Recent Results Cancer Res; 1980; 74():250-7. PubMed ID: 6893753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divergent activity of derivatives of amsacrine (m-AMSA) towards Lewis lung carcinoma and P388 leukaemia in mice.
    Baguley BC; Kernohan AR; Wilson WR
    Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1607-13. PubMed ID: 6688994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the mechanism of action of 4'-[(9-acridinyl)-amino] methanesulphon-m-anisidide.
    Ralph RK
    Eur J Cancer (1965); 1980 May; 16(5):595-600. PubMed ID: 6771143
    [No Abstract]   [Full Text] [Related]  

  • 10. A reassessment of the mechanism of action of 4'-[(9-acridinyl)-amino]methanesulphon-m-anisidide.
    Marshall B; Ralph RK
    Eur J Cancer Clin Oncol; 1982 Jun; 18(6):553-7. PubMed ID: 6811280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on a mode of resistance to m-AMSA.
    Kessel D; Wheeler C; Chou TH; Howard WS; Johnson RK
    Biochem Pharmacol; 1982 Sep; 31(18):3008-10. PubMed ID: 6897191
    [No Abstract]   [Full Text] [Related]  

  • 12. Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino) methanesulfon-m-anisidide and adriamycin.
    Zwelling LA; Michaels S; Erickson LC; Ungerleider RS; Nichols M; Kohn KW
    Biochemistry; 1981 Nov; 20(23):6553-63. PubMed ID: 6895473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprotection by 9-aminoacridine derivatives against the cytotoxicity of topoisomerase II-directed drugs.
    Finlay GJ; Wilson WR; Baguley BC
    Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1695-701. PubMed ID: 2561099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lethal activity and kinetic response of cultured human cells to 4'-(9-acridinylamino)methanesulfon-m-anisidine.
    Drewinko B; Yang LY; Barlogie B
    Cancer Res; 1982 Jan; 42(1):107-11. PubMed ID: 6895609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocked 5'-termini in the fragments of chromosomal DNA produced in cells exposed to the antitumor drug 4'-[(9-acridinyl)-amino]methanesulphon-m-anisidide (mAMSA).
    Marshall B; Ralph RK; Hancock R
    Nucleic Acids Res; 1983 Jun; 11(12):4251-6. PubMed ID: 6306581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of immunosuppressive chemotherapy on immune function in patients with malignant disease.
    Harris J; Sengar D; Stewart T; Hyslop D
    Cancer; 1976 Feb; 37(2 Suppl):1058-69. PubMed ID: 766953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the principal biliary metabolite of 4'-(9-acridinylamino)methanesulfon-m-anisidide in rats.
    Shoemaker DD; Cysyk RL; Padmanabhan S; Bhat HB; Malspeis L
    Drug Metab Dispos; 1982; 10(1):35-9. PubMed ID: 6124380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intercalator-induced, topoisomerase II-mediated DNA cleavage and its modification by antineoplastic antimetabolites.
    Zwelling LA; Silberman L; Estey E
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1041-7. PubMed ID: 2427489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I-II study of m-AMSA administered as a continuous infusion.
    Micetich KC; Zwelling LA; Gormley P; Young RC
    Cancer Treat Rep; 1982 Oct; 66(10):1813-7. PubMed ID: 6897013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II evaluation of m-AMSA (4'-(9-acridinylamino)-methanesulfon-m-anisidide) in patients with adenocarcinoma of the pancreas.
    Sternberg CN; Magill GB; Sordillo PP; Cheng E; Currie VE
    Am J Clin Oncol; 1983 Aug; 6(4):459-62. PubMed ID: 6688151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.